Medical Research
Holstebro, 7500, Denmark
NCT Number: NCT01635231
Urinary biomarkers (u-NKCC2, u-ENaC-gamma and u-AQP2) reflects the activity of the sodium- and water channels in the human kidney.
Changes in the sodium-and water channel activity can be induced by blocking the sodium channels with diuretics in healthy subjects
Looking for future studies?
Notify Me18 year–45 year
All sexes
Interventional
Not applicable
Holstebro, 7500, Denmark
The purpose of this study is to investigate the changes in urinary biomarkers (u-NKCC2, u-ENaC-gamma and u-AQP2), extra- and intracellular fluid compartments, central bloodpressure and the plasma concentration of Vasoactive hormones in healthy subjects under a) treatment with Amiloride and Thiazide at baseline and b) after and acute infusion with hypertonic saline.
Subjects will be examined on three examination days. Four days prior to the examination days the subjects will consume a standard diet based on amount of sodium and calories and randomized to treatment with either thiazide, amiloride or placebo twice daily for 5 days. On the examination days the subjects receive an infusion with hypertonic saline.
Renal function is measured by renal clearance of 51Cr-EDTA. Urinary biomarkers (u-NKCC2, u-ENaC-gamma and u-AQP2) will be measured to evaluate the activity of water- and sodium channels in the nephron, changes in fluid compartments are measured by body composition monitor. Central blood pressure is measured by sphygmocor.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
hypertonic saline 3.0% 7 ml/kg
Other names: NaCl 3.0 %
Time frame: baseline, 0 hours and 1.5 hours after intervention
Urinary excretion of epithelial sodium channels (ENaC), Sodium-potassium-2chloride transporters (NKCC2) and aquaporin2 channels (AQP2) before, during and after fluid infusion
Time frame: baseline, 0 hours and 1.5 hours after intervention
plasma concentrations of: renin, Angiotensin II, aldosterone, Vasopressin, ANP and BNP
Time frame: baseline, 0 hours and 1.5 hours after intervention
measured by applanation-tonometry
Time frame: baseline, 0 hours and 1.5 hours after intervention
change in ICV and EVC from baseline and after intervention measured in liters by body composition monitor (BCM)
Regional Hospital Holstebro
Other
Effect of Thiazide, Amiloride and Hypertonic Saline on Sodium- and Water Channel Activity in the Nephron in Healthy Subjects Estimated by Urinary Biomarkers
Acronym: THAM
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03719339
Acute Cellular Graft Rejection, Antibody-mediated Rejection
La Jolla, California, United States
View Trial DetailsNCT03620773
Adolescent Obesity, Bariatric Surgery Candidate
Aurora, Colorado, United States
View Trial DetailsNCT06806644
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Bologna, Italy
View Trial DetailsNCT02675686
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Amiens, France
View Trial Details